Clinical Trials

1 results for Kidney/Renal Cancer


Cabosun II: Cabozantinib Versus Sunitinib for Metastatic Variant Histology Renal Cell Carcinoma

  • Condition: Malignant Neoplasms of Urinary Tract, Renal Cell Carcinoma
  • Intervention: Drug: Cabozantinib, Drug: Sunitinib
  • Study ID: NCT03541902
View Trial